Skip to content

Researcher Stories

Get to know the PhRMA Foundation’s award recipients.

Missing ALT Text

A New Approach to Treating Fatty Liver Disease

Sergei Kutseikin, a PhD student at Scripps Research Institute, is researching new treatments for fatty liver disease, a condition where fat builds up in the liver, leading to inflammation, liver cell damage, and liver scarring.

Watch Now
Missing ALT Text

Advancing Precision Genome Editing Therapies for Rare Diseases

Dr. Samagya Banskota of Boston University is developing precision genome editing therapeutics that allow scientists to both understand the mutations that cause genetic diseases and develop therapeutic strategies to treat them.

Watch Now
Missing ALT Text

Understanding and Overriding Treatment Resistance in Chronic Myeloid Leukemia

Ariel Leyte-Vidal, a PhD student at the University of Miami Miller School of Medicine, seeks to understand treatment resistance in the blood cancer chronic myeloid leukemia.

Read More

In Vivo CAR T Cell Engineering for More Effective, Affordable Cancer Treatment

Jingyu Zhao, a PhD student at the University of North Carolina at Chapel Hill, is researching how to improve chimeric antigen receptor (CAR) T cell therapy, a powerful treatment for blood cancers.

Awardee Spotlight

Aakriti Gangwal, MSc, PhD

  • Stanford University

“Receiving the PhRMA Foundation Postdoctoral Fellowship is a transformative opportunity. It motivates me to apply my expertise in biochemistry to advancing antiviral research, break barriers, and drive global impact in drug development.”

Identifying Early Biological Warning Signs of Vision Loss

Ying Liu, MD, PhD, a research associate faculty at Johns Hopkins University, is researching new ways to detect retinal degeneration earlier.

PhRMA Foundation
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.